$0.315
0.010 (3.28%)
|
High $0.32 |
Low $0.30 |
Trades 243 |
Turnover $627,825 |
Volume 2,012,212 |
| 30 June 2023 at 4:10pm | ||||
IMMUTEP LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $36,843,036 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (9-Nov) 20,215,263 (1.37%) (219th) |
|
52w High $0.470 |
52w Low $0.020 |
P/E 7.20 |
EPS -0.05 |
[ARTICLE] Immutep drafts in Bell Potter, Jefferies for raising
A news article has been posted about Immutep on the AFR. The article was published around , on 17 June 2021 at 10:38am.
Cancer and auto-immune disease drug developer Immutep landed in front of fund managers on Thursday morning with a capital raising.
Read ArticleIMM was $0.62 at the close of trade on 16 June 2021
Find all articles about Immutep, including others on the AFR, on the media page.
If you were already registered, log in here.
If you were already registered, log in here.